Sensus Healthcare, Inc. (SRTS): Price and Financial Metrics

Sensus Healthcare, Inc. (SRTS): $4.06

0.07 (-1.69%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

SRTS Price/Volume Stats

Current price $4.06 52-week high $6.01
Prev. close $4.13 52-week low $1.79
Day low $3.96 Volume 131,606
Day high $4.14 Avg. volume 172,649
50-day MA $3.40 Dividend yield N/A
200-day MA $2.91 Market Cap 66.51M

SRTS Stock Price Chart Interactive Chart >

SRTS POWR Grades

  • SRTS scores best on the Value dimension, with a Value rank ahead of 78.32% of US stocks.
  • The strongest trend for SRTS is in Stability, which has been heading up over the past 26 weeks.
  • SRTS ranks lowest in Momentum; there it ranks in the 4th percentile.

SRTS Stock Summary

  • The ratio of debt to operating expenses for SENSUS HEALTHCARE INC is higher than it is for about just 9.96% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.15 for SENSUS HEALTHCARE INC; that's greater than it is for only 11% of US stocks.
  • As for revenue growth, note that SRTS's revenue has grown -43.89% over the past 12 months; that beats the revenue growth of merely 5.78% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to SENSUS HEALTHCARE INC, a group of peers worth examining would be GNSS, BIO, PRCT, NURO, and ITCI.
  • Visit SRTS's SEC page to see the company's official filings. To visit the company's web site, go to www.sensushealthcare.com.

SRTS Valuation Summary

  • In comparison to the median Healthcare stock, SRTS's EV/EBIT ratio is 273.97% lower, now standing at -25.4.
  • SRTS's EV/EBIT ratio has moved down 277.4 over the prior 90 months.

Below are key valuation metrics over time for SRTS.

Stock Date P/S P/B P/E EV/EBIT
SRTS 2023-12-29 1.6 0.9 -43.2 -25.4
SRTS 2023-12-28 1.6 0.9 -43.9 -26.2
SRTS 2023-12-27 1.6 0.9 -45.8 -28.5
SRTS 2023-12-26 1.6 0.9 -45.8 -28.5
SRTS 2023-12-22 1.7 0.9 -46.4 -29.3
SRTS 2023-12-21 1.7 0.9 -46.8 -29.7

SRTS Growth Metrics

    Its 3 year price growth rate is now at 53.79%.
  • Its 5 year net cashflow from operations growth rate is now at 272.64%.
  • Its year over year cash and equivalents growth rate is now at 139.56%.
Over the past 33 months, SRTS's revenue has gone up $17,189,752.

The table below shows SRTS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 44.453 6.921 26.733
2022-06-30 40.968 4.451 25.099
2022-03-31 34.31 3.911 21.296
2021-12-31 27.042 -0.286 4.119
2021-09-30 19.11137 1.133581 -0.180585
2021-06-30 15.20654 -2.75986 -2.067838

SRTS Price Target

For more insight on analysts targets of SRTS, see our SRTS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $4.43 Average Broker Recommendation 1.5 (Moderate Buy)

Sensus Healthcare, Inc. (SRTS) Company Bio


Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides Sentinel service program, which offers its customers protection for their SRT-100 and SRT-100 Vision systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is based in Boca Raton, Florida.


SRTS Latest News Stream


Event/Time News Detail
Loading, please wait...

SRTS Latest Social Stream


Loading social stream, please wait...

View Full SRTS Social Stream

Latest SRTS News From Around the Web

Below are the latest news stories about SENSUS HEALTHCARE INC that investors may wish to consider to help them evaluate SRTS as an investment opportunity.

Q3 2023 Sensus Healthcare Inc Earnings Call

Q3 2023 Sensus Healthcare Inc Earnings Call

Yahoo | November 10, 2023

Sensus Healthcare Reports Third Quarter 2023 Financial Results

Revenues of $3.9 million reflect seasonality and macroeconomic conditions Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and nine months ended September 30, 2023. Highlights from the third

Yahoo | November 9, 2023

Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023

BOCA RATON, Fla, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 9, 2023 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter of 2023. In addition, management will provide a business update and a discussion on recent and upcoming mile

Yahoo | November 2, 2023

Sensus Healthcare (NASDAQ:SRTS) Shareholders Will Want The ROCE Trajectory To Continue

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

Yahoo | October 13, 2023

Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference

BOCA RATON, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will deliver a company presentation and hold investor meetings at the Roth MKM 2023 Healthcare Opportunities Conference being held October 12, 2023 in New York City. Sensus management will also participate in the

Yahoo | October 9, 2023

Read More 'SRTS' Stories Here

SRTS Price Returns

1-mo 28.48%
3-mo 61.75%
6-mo 32.68%
1-year -34.20%
3-year -4.92%
5-year -44.84%
YTD 72.03%
2023 -68.19%
2022 2.77%
2021 87.05%
2020 9.04%
2019 -52.23%

Continue Researching SRTS

Want to see what other sources are saying about Sensus Healthcare Inc's financials and stock price? Try the links below:

Sensus Healthcare Inc (SRTS) Stock Price | Nasdaq
Sensus Healthcare Inc (SRTS) Stock Quote, History and News - Yahoo Finance
Sensus Healthcare Inc (SRTS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!